跳至主要内容
临床试验/NL-OMON26862
NL-OMON26862已完成不适用

Intradiscal Methylene Blue Injection Treatment for Chronic Discogenic Low back pain.

MUMC-Maastricht University Medical CentreDepartment of Anesthesiology and pain managementPO Box 58006202 AZ MaastrichtThe Netherlands. Addition 8-10-2013: Financed by ZonMW. The study is carried out in 2 additional centra.0 个研究点目标入组 63 人开始时间: 待定最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
63

研究概览

简要总结

/A

研究设计

研究类型
Interventional

入排标准

入选标准

  • 1. Axial low back pain of presumed discogenic origin of at least 6 months duration and non responsive to treatment of at least 6 months conservative medical management;
  • 2. History consistent with discogenic low back pain ( e.g. predominant axial pain produced on lumbar motion, significant functional limitation in sitting duration and tolerance);

排除标准

  • 1. Severe disc degeneration at the affected level as evidenced by >50% disc height loss on plain anteroposterior and lateral lumbar radiographs or CT/MRI;
  • 2. Extruded or sequestered herniated nucleus pulposus at the affected level(s);

研究者

发起方
MUMC-Maastricht University Medical CentreDepartment of Anesthesiology and pain managementPO Box 58006202 AZ MaastrichtThe Netherlands. Addition 8-10-2013: Financed by ZonMW. The study is carried out in 2 additional centra.

相似试验